These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18630506)

  • 1. Inhibition of steroid sulphatase activity via the percutaneous route: a new option for breast cancer therapy.
    Purohit A; Chander SK; Woo LW; Parsons MF; Jhalli R; Potter BV; Reed MJ
    Anticancer Res; 2008; 28(3A):1517-23. PubMed ID: 18630506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of three potent steroid sulfatase inhibitors: pre-clinical investigations for their use in the treatment of hormone-dependent breast cancer.
    Foster PA; Chander SK; Parsons MF; Newman SP; Woo LW; Potter BV; Reed MJ; Purohit A
    Breast Cancer Res Treat; 2008 Sep; 111(1):129-38. PubMed ID: 17914670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid sulfatase: a new target for the endocrine therapy of breast cancer.
    Stanway SJ; Delavault P; Purohit A; Woo LW; Thurieau C; Potter BV; Reed MJ
    Oncologist; 2007 Apr; 12(4):370-4. PubMed ID: 17470679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo efficacy of STX213, a second-generation steroid sulfatase inhibitor, for hormone-dependent breast cancer therapy.
    Foster PA; Newman SP; Chander SK; Stengel C; Jhalli R; Woo LL; Potter BV; Reed MJ; Purohit A
    Clin Cancer Res; 2006 Sep; 12(18):5543-9. PubMed ID: 17000691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of steroid sulfatase inhibitors for hormone-dependent cancer therapy.
    Day JM; Purohit A; Tutill HJ; Foster PA; Woo LW; Potter BV; Reed MJ
    Ann N Y Acad Sci; 2009 Feb; 1155():80-7. PubMed ID: 19250195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitor.
    Foster PA; Chander SK; Newman SP; Woo LW; Sutcliffe OB; Bubert C; Zhou D; Chen S; Potter BV; Reed MJ; Purohit A
    Clin Cancer Res; 2008 Oct; 14(20):6469-77. PubMed ID: 18927286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-[2-(adamantylidene)-hydroxybenzoxazole]-O-sulfamate, a steroid sulfatase inhibitor for the treatment of androgen- and estrogen-dependent diseases.
    Billich A; Meingassner JG; Nussbaumer P; Desrayaud S; Lam C; Winiski A; Schreiner E
    J Steroid Biochem Mol Biol; 2004 Sep; 92(1-2):29-37. PubMed ID: 15544928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of novel steroid sulfatase inhibitors; II. TZS-8478 potently inhibits the growth of breast tumors in postmenopausal breast cancer model rats.
    Saito T; Kinoshita S; Fujii T; Bandoh K; Fuse S; Yamauchi Y; Koizumi N; Horiuchi T
    J Steroid Biochem Mol Biol; 2004 Feb; 88(2):167-73. PubMed ID: 15084348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase.
    Woo LW; Howarth NM; Purohit A; Hejaz HA; Reed MJ; Potter BV
    J Med Chem; 1998 Mar; 41(7):1068-83. PubMed ID: 9544207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid sulphatase inhibitors for breast cancer therapy.
    Purohit A; Woo LW; Chander SK; Newman SP; Ireson C; Ho Y; Grasso A; Leese MP; Potter BV; Reed MJ
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):423-32. PubMed ID: 14623540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of 2-methoxyoestrogen sulphamates on the in vitro and in vivo proliferation of breast cancer cells.
    Utsumi T; Leese MP; Chander SK; Gaukroger K; Purohit A; Newman SP; Potter BV; Reed MJ
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):219-27. PubMed ID: 15862969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of steroid sulfatase inhibitors.
    Woo LW; Purohit A; Potter BV
    Mol Cell Endocrinol; 2011 Jul; 340(2):175-85. PubMed ID: 21238537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo inhibition of oestrone sulphatase and dehydroepiandrosterone sulphatase by oestrone-3-O-sulphamate.
    Purohit A; Williams GJ; Roberts CJ; Potter BV; Reed MJ
    Int J Cancer; 1995 Sep; 63(1):106-11. PubMed ID: 7558436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nature of inhibition of steroid sulphatase activity by tibolone and its metabolites.
    Raobaikady B; Day JM; Purohit A; Potter BV; Reed MJ
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):229-37. PubMed ID: 15862970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of oestrone sulphatase activity by tibolone and its metabolites.
    Purohit A; Malini B; Hooymans C; Newman SP
    Horm Metab Res; 2002 Jan; 34(1):1-6. PubMed ID: 11832993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control and expression of oestrone sulphatase activities in human breast cancer.
    Pasqualini JR; Chetrite G; Nestour EL
    J Endocrinol; 1996 Sep; 150 Suppl():S99-105. PubMed ID: 8943793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, in vitro and in vivo activity of benzophenone-based inhibitors of steroid sulfatase.
    Hejaz HA; Woo LW; Purohit A; Reed MJ; Potter BV
    Bioorg Med Chem; 2004 May; 12(10):2759-72. PubMed ID: 15110857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor.
    Stanway SJ; Purohit A; Woo LW; Sufi S; Vigushin D; Ward R; Wilson RH; Stanczyk FZ; Dobbs N; Kulinskaya E; Elliott M; Potter BV; Reed MJ; Coombes RC
    Clin Cancer Res; 2006 Mar; 12(5):1585-92. PubMed ID: 16533785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of hormone therapy on E1S-sulfatase activity in non-malignant and cancerous breast cells in vitro.
    Stute P; Götte M; Kiesel L
    Breast Cancer Res Treat; 2008 Apr; 108(3):363-74. PubMed ID: 17546497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of steroid sulfatase inhibitors as a novel therapeutic strategy against hormone-dependent endometrial cancer.
    Foster PA; Woo LW; Potter BV; Reed MJ; Purohit A
    Endocrinology; 2008 Aug; 149(8):4035-42. PubMed ID: 18450955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.